Ticker
RIGLCompany Name
RIGEL PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
---|---|---|---|
6/30/2025 | 46.08% | $ 65.89M | $ 142.98M |
3/31/2025 | 44.49% | $ 35.43M | $ 79.63M |
12/31/2024 | 49.28% | $ 31.17M | $ 63.25M |
9/30/2024 | 23.02% | $ 10.49M | $ 45.59M |
6/30/2024 | -41.22% | $ -12.54M | $ 30.42M |
3/31/2024 | -23.2% | $ -6.69M | $ 28.83M |
12/31/2023 | -17.17% | $ -5.48M | $ 31.93M |
9/30/2023 | -72.46% | $ -20.99M | $ 28.96M |
6/30/2023 | -100.94% | $ -32.86M | $ 32.55M |
3/31/2023 | -140.91% | $ -51.4M | $ 36.48M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Inv. Capital
(=) CROIC
CROIC for RIGEL PHARMACEUTICALS INC is calculated as follows: FCF [ $ -47.63M ] / Inv. Capital [ $ 92.05M ]
(=) CROIC [ -51.74% ]
Minimum
Sep 30, 2022
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.46K |
---|---|
min | -43.7% |
max | 49.3% |
average | 2.82% |
median | 4.98% |
std | 15.01% |